Giyani's High Purity Manganese Oxide Phase 2 Interim Results From Charge CCCV's Digital DNA Program

• Giyani Metals Corp. announced interim Phase 2 results from C4V's Digital DNA Supply Chain Qualification Program for its High-Purity Manganese Oxide (HPMO).
• HPMO samples met quality assurance standards; electrode density and rate testing show consistency comparable to baseline electrodes.
• Capacity retention in cells using Giyani's HPMO is comparable to baseline cells during long cycling.
• Phase 2 completion (80% retained capacity) expected within ~60 days.
• Phase 3 multi-layer pouch cell testing will follow, taking approximately six months.
• Definitive Feasibility Study (DFS) remains on track for release "within the current quarter" (Q2 2026).
• Company has developed a flowsheet to produce both HPMO and High-Purity Manganese Sulphate Monohydrate (HPMSM).

• The news confirms technical progress but does not introduce new financial upside or revenue milestones.
• DFS timeline aligns with the March 2026 update which pushed completion to Q2 2026; no surprise delay or acceleration.
• Phase 2 validation is a necessary step for off-take qualification but does not guarantee commercial contracts yet.
• The "current quarter" (Q2) DFS target matches previous guidance, reducing uncertainty but extending the path to project financing.
• No new capital raise announced in this release; reliance remains on existing facilities and contingent EXIM LOI.

• Company: Giyani Metals Corp., focused on battery-grade manganese production.
• Flagship Project: K.Hill High-Purity Manganese Oxide (HPMO) and HPMSM project in Botswana.
• Current Status: Demonstration plant operational in Johannesburg; producing HPMO and HPMSM for qualification testing.
• Product Application: Precursors for LMFP, NMC, and other high-manganese EV battery chemistries.
• Timeline: Commercial plant construction targeted for 2027 with ramp-up in 2028/2029 (subject to DFS completion).